-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
It's not a flattering thing to start with, it's a hard work to fight for strength.
That year Qiao Feng recruitment after the first, the enemy to win, because there are many years of hard work from the power of the people;
last time I wrote "Drugs don't have to make money?" It's not easy to point out that Me Too drugs want to make money back, because the market share of the first two listed drugs is too high.
readers have questioned that There are many examples of Me Too's successful counter-attacks, so they can't be general.
: "Happy families are similar, but unhappy families have their own misfortunes," wrote Russia's Wenhaulev Tolstoy at the opening of Anna Karenina.
"What I'm trying to say is this: Me Too who doesn't make money is similar, and Me Too who doesn't make money has its own mysteries, and it really can't be general."
the same as before, let's clarify the definition of Me Too and reach a consensus.
do you define MeToo? Personally, I don't think a project can count as Me Too 2 before the results of a clinical trial of the first relevant target are published.
because these projects don't learn anything substantial from previous projects, especially if you want to do it fast and want to bend over.
we might as well call these projects "quick follow-up".
the results of the first clinical trial, whether successful or failed, were published.
Based on your analysis and judgment of the results of this clinical trial, and then deciding to set up the same project to develop drugs of the same target, this is the real Me Too, because someone has done an important proof of concept, whether successful or not.
but conversely, the FIC (First in Class) is not defined by the time of the project, but by the approval of the listing.
this is mainly because in most cases the company's project time is not public information, and the time to approve the listing is not only accountable, but also the company will certainly make a big publicity.
I've argued for a long time (by Me Better's chloro-rays) that drugs that go on sale within a year of FIC shouldn't be Me Too, they're "me Too."
it possible to go first after the meeting? Readers who like Jin Yong can recall (or reread) The vicious battle of Qiao Feng in Juxianzhuang with one to ten.
In order to avoid the suspicion of the Liao people, he made the Central Plains Wugong Song Zu long fist, no complicated tricks, but with the internal strength of each after each first, restrain the opponent.
this is what we often say: the world martial arts, only fast not broken.
because Me Too and FIC are different in definition, there is a possibility of "first come, first between": someone has been clinically at the time of the project, and the results have been published, so it is a typical Me Too project.
But in the process of advancing timely to avoid all kinds of already appeared "pits and bumps", (generally with the help of the front-runner's mistakes), the success of the curve overstep, became the first drug on the market, so it met the definition of FIC.
is both Me Too and FIC, don't you think it's weird? Sitagliptin, which I've experienced first-hand, is just one of those Me Too Firsts.
can I get back first? Siglitin's story has been told many times and will not be repeated here.
if you're still feeling strange, it's recommended to read the relevant chapters of The Story of the New Drug, or have a chance to come to my class.
The Story of Advertising New Drugs ("Post-Antibiotic Disaster" Era, Dr. Liang Guibai of the Merca East Institute of New Medicines, Scientists Teach You to Think Rationally about Disease) Liang Guibai when Advertising New Drugs 2 (Ten Heavy Drugs That Change the Troubles, Witnessing the tortuous history of human challenges) Liang Guibaiddan because the current Me Too project in the domestic pharmaceutical industry is mainstream, so we must be concerned about how to like Mercedon's Sigretin later on, become Me Too First, occupy the majority of the market share.
, it is not a flattering thing to start first, but a hard work of hard work to fight for strength.
That year, Qiao Feng recruited first, the enemy won, because there are many years of hard work from the power of people;
), making the industry look good, but also because of strong research and development capabilities and the courage to press the whole line (All In!). The courage of the two is indispensable.
scientists who worked at the Merca East Institute for New Medicines (MRL) at the end of the last century probably experienced the sensational "Manhattan Project", which is also a wonder of the industry.